Europe Sleep Apnea Therapeutics and Diagnostics Market 2021-2028

A report insinuates that the sleep apnea therapeutics and diagnostics market in Europe is likely to progress with a CAGR of 6.61% between the forecast years 2021-2028. The United Kingdom, France, Spain, Germany, Russia, Italy, and Rest of Europe together shape the market in this region.

The market in Italy is emerging, and its growth is driven primarily by the favorable reimbursement landscape and enhanced usage of oral appliances to treat sleep apnea treatment. However, the lack of treatment adherence by patients majorly restrains the market development here. Owing to this, the usage of custom-made oral appliances has increased significantly.

For instance, the study by Elsevier on oral appliances for obstructive sleep apnea, in 2019, stated that the development of titratable, custom-made oral appliances is likely reduce the degree of mandibular advancement of the jaw as well as the apneic incidences simultaneously. The decreased level of mandibular advancement would improve medical adherence to oral therapy.

The prevalence of sleep apnea in Spain is also significantly high. For instance, as per the study by Lancet on the prevalence and burden of obstructive sleep apnea across the globe, in July 2019, 16.20% of the Spanish population, in the age group of 30 to 69 years, was affected by moderate to severe sleep apnea. The market here is majorly driven by regional companies like OrthoApnea SA, and a favorable reimbursement landscape.

COMPETITIVE OUTLOOK

Some of the players dominating the sleep apnea therapeutics and diagnostics market include Koninklijke Philips NV, Braebon Medical Corporation, Itamar Medical Ltd, BMC Medical Co Ltd, Resmed Inc, Cadwell Industries Inc, GE Healthcare (General Electric Company), and Medtronic PLC.

1. Europe Sleep Apnea Therapeutics and Diagnostics Market - Summary

2. Industry Outlook

2.1. Impact of Covid-19 on the Sleep Apnea Therapeutics and Diagnostics Market
2.2. Key Insights
2.3. Porter's Five Forces Model
2.3.1. Bargaining Power of Buyers
2.3.2. Bargaining Power of Suppliers
2.3.3. Threat of Substitute Products
2.3.4. Threat of New Entrants
2.3.5. Competitive Rivalry
2.4. Legal, Policy & Regulatory Framework
2.5. Supply Chain Outlook
2.6. Market Attractiveness Index
2.7. Vendor Scorecard
2.8. Key Market Strategies
2.8.1. Acquisitions & Mergers
2.8.2. New Product Launches & Developments
2.8.3. Contracts and Partnerships
2.8.4. Business Expansions, Announcements & Divestitures
2.9. Market Drivers
2.9.1. Awareness Related to the Negative Impact of Untreated Sleep Apnea
2.9.2. Rise in Geriatric Population and Obesity Cases
2.9.3. Disturbed Sleep Due to Increased Use of Gadgets at Night-Time
2.10. Market Challenges
2.10.1. High Cost of Sleep Apnea Devices
2.10.2. Unfavorable Reimbursement Landscape
2.10.3. Lack of Patient Adherence to the Treatment Recommended
2.11. Market Opportunities
2.11.1. Increasing Usage of At-Home Monitoring Devices
2.11.2. Advancements in Technology

3. Europe Sleep Apnea Therapeutics and Diagnostics Market - by Product Type

3.1. Therapeutics
3.1.1. Positive Airway Pressure (Pap) Devices
3.1.2. Oxygen Devices
3.1.3. Masks and Accessories
3.1.4. Oral Appliances
3.1.5. Adaptive Servo Ventilation (Asv) Devices
3.2. Diagnostics and Monitoring
3.2.1. Polysomnography Device (Psg)
3.2.2. Oximeter
3.2.3. Actigraphy Monitoring Device
3.2.4. Respiratory Polygraph
3.2.5. Sleep Apnea Screening Device
3.2.6. Other Diagnostics and Monitoring Devices

4. Europe Sleep Apnea Therapeutics and Diagnostics Market - by Industry Verticals

4.1. Hospitals & Sleep Laboratories
4.2. Home Care Settings

5. Geographical Analysis - Europe

5.1. Country Analysis
5.1.1. Germany
5.1.2. France
5.1.3. United Kingdom
5.1.4. Italy
5.1.5. Russia
5.1.6. Spain
5.1.7. Rest of Europe

6. Competitive Landscape

6.1. Bmc Medical Co Ltd
6.2. Braebon Medical Corporation
6.3. Cadwell Industries Inc
6.4. Devilbiss Healthcare LLC
6.5. Fisher & Paykel Healthcare Corporation Limited
6.6. GE Healthcare (General Electric Company)
6.7. Invacare Corporation
6.8. Itamar Medical Ltd
6.9. Koninklijke Philips Nv
6.10. Medtronic plc
6.11. Nihon Kohden Corporation
6.12. Signifier Medical Technologies Limited
6.13. Resmed Inc
6.14. Smiths Medical Inc
6.15. Somnomedics GmbH
6.16. Teleflex Incorporated
6.17. Vyaire Medical Inc

7. Research Methodology & Scope

7.1. Research Scope & Deliverables
7.1.1. Objectives of Study
7.1.2. Scope of Study
7.2. Sources of Data
7.2.1. Primary Data Sources
7.2.2. Secondary Data Sources
7.3. Research Methodology
7.3.1. Evaluation of Proposed Market
7.3.2. Identification of Data Sources
7.3.3. Assessment of Market Determinants
7.3.4. Data Collection
7.3.5. Data Validation & Analysis

List of Tables

Table 1: Europe Sleep Apnea Therapeutics and Diagnostics Market, Country Outlook, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Acquisitions & Mergers
Table 4: New Product Launches & Developments
Table 5: Contracts and Partnerships
Table 6: Business Expansions, Announcements & Divestitures
Table 7: Europe Sleep Apnea Therapeutics and Diagnostics Market, by Product Type, 2021-2028 (In $ Million)
Table 8: Europe Therapeutics Market, by Type, 2021-2028 (In $ Million)
Table 9: Europe Diagnostics and Monitoring Market, by Type, 2021-2028 (In $ Million)
Table 10: Europe Sleep Apnea Therapeutics and Diagnostics Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 11: Europe Sleep Apnea Therapeutics and Diagnostics Market, by Country, 2021-2028 (In $ Million)

List of Figures

Figure 1: Europe Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 2: Porter's Five Forces Model
Figure 3: Europe Sleep Apnea Therapeutics and Diagnostics Market, by Product Type, 2020 & 2028 (In %)
Figure 4: Europe Sleep Apnea Therapeutics and Diagnostics Market, by Therapeutics, 2021-2028 (In $ Million)
Figure 5: Europe Sleep Apnea Therapeutics Market, by Positive Airway Pressure (Pap) Devices, 2021-2028 (In $ Million)
Figure 6: Europe Sleep Apnea Therapeutics Market, by Oxygen Devices, 2021-2028 (In $ Million)
Figure 7: Europe Sleep Apnea Therapeutics Market, by Masks and Accessories, 2021-2028 (In $ Million)
Figure 8: Europe Sleep Apnea Therapeutics Market, by Oral Appliances, 2021-2028 (In $ Million)
Figure 9: Europe Sleep Apnea Therapeutics Market, by Adaptive Servo Ventilation (Asv) Devices, 2021-2028 (In $ Million)
Figure 10: Europe Sleep Apnea Therapeutics and Diagnostics Market, by Diagnostics and Monitoring, 2021-2028 (In $ Million)
Figure 11: Europe Diagnostics and Monitoring Market, by Polysomnography Device (Psg), 2021-2028 (In $ Million)
Figure 12: Europe Diagnostics and Monitoring Market, by Oximeter, 2021-2028 (In $ Million)
Figure 13: Europe Diagnostics and Monitoring Market, by Actigraphy Monitoring Device, 2021-2028 (In $ Million)
Figure 14: Europe Diagnostics and Monitoring Market, by Respiratory Polygraph, 2021-2028 (In $ Million)
Figure 15: Europe Diagnostics and Monitoring Market, by Sleep Apnea Screening Device, 2021-2028 (In $ Million)
Figure 16: Europe Diagnostics and Monitoring Market, by Other Diagnostics and Monitoring Devices, 2021-2028 (In $ Million)
Figure 17: Europe Sleep Apnea Therapeutics and Diagnostics Market, by Industry Verticals, 2020 & 2028 (In %)
Figure 18: Europe Sleep Apnea Therapeutics and Diagnostics Market, by Hospitals & Sleep Laboratories, 2021-2028 (In $ Million)
Figure 19: Europe Sleep Apnea Therapeutics and Diagnostics Market, by Home Care Settings, 2021-2028 (In $ Million)
Figure 20: Germany Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 21: France Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 22: United Kingdom Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 23: Italy Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 24: Russia Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 25: Spain Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 26: Rest of Europe Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)